The data released by the president of Farmindustria, Marcello Cattani, on the occasion of World Cancer Day.
“Today in Italy 1 million more people survive after one tumor diagnosis compared to 10 years ago. A result that is also due to the enormous progress made in pharmaceutical research. In the country, according to the Italian Medicines Agency (AIFA), 40% of clinical studies concern neoplasms.
Globally, 237 new medicines for the treatment of cancer have been launched in the last 20 years, with almost half (115) in the last five years. And the pipeline of molecules in development in the world is 8 thousand out of 21 thousand in total and over 2,000 products already in the clinical phase”.
Thus the president of Farmindustria, Marcello Cattanion the occasion of World Cancer Daywhich is celebrated on February 4th.
“Oncology research offers opportunities that were unthinkable until recently, thanks also to artificial intelligence that is increasingly integrated into the research and development processes of new molecules, chemical or biotech synthesis, cell and gene therapies, vaccines,” added Cattani.
“Steps forward that have made it possible to increase patients’ life expectancy and reduce hospitalizations. Even more can be done with research, with quicker access to treatments and with prevention, starting with lifestyles. In fact, there could be up to 40% fewer cases by eliminating or modifying risk factors such as smoke, obesityalcohol and physical inactivity”.
“A cultural action – he continued – which must be accompanied by the strengthening of screening and territorial homogeneity in access to oncological treatments. A gap that must be filled, as underlined by the title of this year’s Day, also at an international level. Because in an era of galloping innovation it is everyone’s duty, with collaborative and synergistic action, to ensure essential health services – from prevention to treatment – to the citizens of the world“.
Read also: Melanoma, first Italian patient to receive the anti-cancer vaccine